| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Rhythm control versus rate control for atrial fibrillation and heart failure.
|
N Engl J Med
|
2008
|
6.17
|
|
2
|
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial.
|
Circulation
|
2013
|
2.90
|
|
3
|
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
|
J Am Coll Cardiol
|
2006
|
2.68
|
|
4
|
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds.
|
Circulation
|
2011
|
2.36
|
|
5
|
Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis.
|
J Thorac Cardiovasc Surg
|
2007
|
2.24
|
|
6
|
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
|
Circulation
|
2003
|
2.16
|
|
7
|
Transmural action potential and ionic current remodeling in ventricles of failing canine hearts.
|
Am J Physiol Heart Circ Physiol
|
2002
|
2.00
|
|
8
|
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care.
|
Can J Cardiol
|
2011
|
1.78
|
|
9
|
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.
|
J Am Coll Cardiol
|
2004
|
1.72
|
|
10
|
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.
|
Can J Cardiol
|
2007
|
1.70
|
|
11
|
Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD).
|
Circulation
|
2003
|
1.69
|
|
12
|
Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: first in man experience with a temporary implant.
|
Catheter Cardiovasc Interv
|
2007
|
1.53
|
|
13
|
Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.
|
Cardiovasc Res
|
2008
|
1.51
|
|
14
|
Late iatrogenic coronary stenosis after selective intraoperative antegrade myocardial protection for stentless aortic valve replacement.
|
J Thorac Cardiovasc Surg
|
2006
|
1.48
|
|
15
|
Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
|
Circ Heart Fail
|
2012
|
1.48
|
|
16
|
Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System.
|
Catheter Cardiovasc Interv
|
2007
|
1.45
|
|
17
|
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.
|
Can J Cardiol
|
2012
|
1.44
|
|
18
|
Challenge of informing patient decision making: what can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-of-life issues?
|
Circ Cardiovasc Qual Outcomes
|
2014
|
1.41
|
|
19
|
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
|
J Am Coll Cardiol
|
2003
|
1.39
|
|
20
|
Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy.
|
Hypertension
|
2007
|
1.29
|
|
21
|
Cardiac masses: an integrative approach using echocardiography and other imaging modalities.
|
Heart
|
2011
|
1.29
|
|
22
|
Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction.
|
J Mol Cell Cardiol
|
2003
|
1.23
|
|
23
|
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.
|
Can J Cardiol
|
2008
|
1.15
|
|
24
|
Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial.
|
Circulation
|
2005
|
1.07
|
|
25
|
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.
|
Can J Cardiol
|
2009
|
1.04
|
|
26
|
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
|
Clin Sci (Lond)
|
2006
|
1.00
|
|
27
|
The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.
|
Can J Cardiol
|
2010
|
1.00
|
|
28
|
Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure.
|
J Card Fail
|
2007
|
0.96
|
|
29
|
Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.
|
J Card Fail
|
2003
|
0.91
|
|
30
|
Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
|
Am Heart J
|
2006
|
0.90
|
|
31
|
Role of transesophageal echocardiography in percutaneous aortic valve replacement with the CoreValve Revalving system.
|
Echocardiography
|
2008
|
0.88
|
|
32
|
Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure.
|
J Card Fail
|
2010
|
0.88
|
|
33
|
Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy.
|
Can J Cardiol
|
2007
|
0.87
|
|
34
|
Are there sex-related differences in specialized, multidisciplinary congestive heart failure clinics?
|
Can J Cardiol
|
2007
|
0.86
|
|
35
|
Factors related to time to admission to specialized multidisciplinary clinics in patients with congestive heart failure.
|
Can J Cardiol
|
2009
|
0.86
|
|
36
|
Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors.
|
J Heart Lung Transplant
|
2010
|
0.83
|
|
37
|
Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics.
|
Can J Cardiol
|
2011
|
0.82
|
|
38
|
Identifying relative cut-off scores with neural networks for interpretation of the Minnesota Living with Heart Failure questionnaire.
|
Conf Proc IEEE Eng Med Biol Soc
|
2009
|
0.81
|
|
39
|
Eosinophilic endomyocarditis: an unusual cause of heart failure in a young patient.
|
Can J Cardiol
|
2011
|
0.81
|
|
40
|
Coronary artery noninvasive imaging in adult Kawasaki disease.
|
Clin Imaging
|
2009
|
0.80
|
|
41
|
Severity at entry to specialized heart failure clinics: discrepancies between health-related quality of life and function in men and women.
|
Can J Cardiol
|
2011
|
0.80
|
|
42
|
Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
|
Can J Cardiol
|
2011
|
0.79
|
|
43
|
Percent predicted value for the 6-minute walk test: using norm-referenced equations to characterize severity in persons with CHF.
|
J Card Fail
|
2008
|
0.79
|
|
44
|
Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study.
|
Int J Cardiol
|
2011
|
0.79
|
|
45
|
Mitral annular reduction with subablative therapeutic ultrasound: pre-clinical evaluation of the ReCor device.
|
EuroIntervention
|
2010
|
0.79
|
|
46
|
Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan.
|
Ann Pharmacother
|
2008
|
0.79
|
|
47
|
Hemodynamic and clinical benefits associated with chronic sildenafil therapy in advanced heart failure: experience of the Montréal Heart Institute.
|
Can J Cardiol
|
2011
|
0.79
|
|
48
|
Inhibiting the renin-angiotensin system with ACE Inhibitors or ARBs after MI.
|
Curr Heart Fail Rep
|
2007
|
0.78
|
|
49
|
Temporal increases in subclinical levels of inflammation are associated with adverse clinical outcomes in patients with left ventricular dysfunction.
|
J Card Fail
|
2006
|
0.78
|
|
50
|
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
|
Am Heart J
|
2005
|
0.77
|
|
51
|
Noninvasive assessment of coronary artery disease in diabetic patients: the role of stress echocardiography.
|
Can J Cardiol
|
2006
|
0.77
|
|
52
|
Should eligibility for heart transplantation be a requirement for left ventricular assist device use? Recommendations based on a systematic review.
|
Can J Cardiol
|
2013
|
0.77
|
|
53
|
An unusual case of giant cell myocarditis missed in a Heartmate-2 left ventricle apical-wedge section: a case report and review of the literature.
|
J Cardiothorac Surg
|
2013
|
0.77
|
|
54
|
Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
|
Am J Cardiol
|
2003
|
0.77
|
|
55
|
Description and assessment of a common reference method for fluoroscopic and transesophageal echocardiographic localization and guidance of mitral periprosthetic transcatheter leak reduction.
|
JACC Cardiovasc Interv
|
2011
|
0.77
|
|
56
|
Lack of long-term benefits of a 6-month heart failure disease management program.
|
J Card Fail
|
2007
|
0.77
|
|
57
|
Dynamic quantitative echocardiographic evaluation of mitral regurgitation in the operating department.
|
J Am Soc Echocardiogr
|
2006
|
0.76
|
|
58
|
Long-term evolution, secular trends, and risk factors of renal dysfunction following cardiac transplantation.
|
Transpl Int
|
2014
|
0.76
|
|
59
|
Outcomes for women and men who attend a heart failure clinic: results of a 12-month longitudinal study.
|
J Card Fail
|
2011
|
0.76
|
|
60
|
Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD.
|
Can J Cardiol
|
2008
|
0.75
|
|
61
|
Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).
|
Can J Cardiol
|
2008
|
0.75
|
|
62
|
Update on the use of trandolapril in the management of cardiovascular disorders.
|
Vasc Health Risk Manag
|
2008
|
0.75
|
|
63
|
PRKCB is associated with calcineurin inhibitor-induced renal dysfunction in heart transplant recipients.
|
Pharmacogenet Genomics
|
2012
|
0.75
|
|
64
|
Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalapril.
|
Am Heart J
|
2005
|
0.75
|
|
65
|
Role of echocardiography in acute myocardial infarction.
|
Curr Heart Fail Rep
|
2008
|
0.75
|
|
66
|
Multiplanar transesophageal echocardiography for the evaluation and percutaneous management of ostium secundum atrial septal defects in the adult.
|
Arch Cardiol Mex
|
2012
|
0.75
|
|
67
|
Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
|
Clin Ther
|
2004
|
0.75
|
|
68
|
Cloth tears in asymptomatic survivors of aortic valve replacement with Starr-Edwards prostheses: detection by transesophageal echocardiography.
|
J Am Soc Echocardiogr
|
2003
|
0.75
|
|
69
|
An unusual case of a giant aneurysm of the ascending aorta.
|
Can J Cardiol
|
2003
|
0.75
|